MannKind Corporation (MNKD) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
MannKind Corporation (MNKD) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $991.7M, listed on NASDAQ, employing roughly 403 people, carrying a beta of 1.04 to the broader market. MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. Led by Michael E. Castagna, public since 2004-07-28.
Snapshot as of May 15, 2026.
- Spot Price
- $3.08
- Total OI
- 97.3K